A citation-based method for searching scientific literature

Paolo Spagnolo, Oliver Distler, Christopher J Ryerson, Argyris Tzouvelekis, Joyce S Lee, Francesco Bonella, Demosthenes Bouros, Anna-Maria Hoffmann-Vold, Bruno Crestani, Eric L Matteson. Ann Rheum Dis 2021
Times Cited: 15







List of co-cited articles
68 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
383
33

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
26

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
Peter M George, Paolo Spagnolo, Michael Kreuter, Goksel Altinisik, Martina Bonifazi, Fernando J Martinez, Philip L Molyneaux, Elisabetta A Renzoni, Luca Richeldi, Sara Tomassetti,[...]. Lancet Respir Med 2020
46
26

Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Toby M Maher, Tamera J Corte, Clare R Sander, Jonathan Ratoff, Anand Devaraj,[...]. Am J Respir Crit Care Med 2008
570
20

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Anna-Maria Hoffmann-Vold, Yannick Allanore, Margarida Alves, Cathrine Brunborg, Paolo Airó, Lidia P Ananieva, László Czirják, Serena Guiducci, Eric Hachulla, Mengtao Li,[...]. Ann Rheum Dis 2021
17
20

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
20

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Pierre-Antoine Juge, Joyce S Lee, Esther Ebstein, Hiroshi Furukawa, Evgenia Dobrinskikh, Steven Gazal, Caroline Kannengiesser, Sébastien Ottaviani, Shomi Oka, Shigeto Tohma,[...]. N Engl J Med 2018
129
20

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Vincent Cottin, Nikhil A Hirani, David L Hotchkin, Anoop M Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K Poonyagariyagorn, Wim Wuyts,[...]. Eur Respir Rev 2018
116
20

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
20

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
368
20

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Athol U Wells, Kevin R Flaherty, Kevin K Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A Wuyts, Susanne Stowasser,[...]. Lancet Respir Med 2020
95
20

Interstitial lung disease in connective tissue disorders.
Aryeh Fischer, Roland du Bois. Lancet 2012
195
20

Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Ekin Oktay Oguz, Orhan Kucuksahin, Murat Turgay, Mustafa Turgut Yildizgoren, Askin Ates, Nalan Demir, Ozlem Ozdemir Kumbasar, Gulay Kinikli, Nursen Duzgun. Clin Rheumatol 2016
30
20

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Yossra A Suliman, Rucsandra Dobrota, Dörte Huscher, Thi D L Nguyen-Kim, Britta Maurer, Suzana Jordan, Rudolf Speich, Thomas Frauenfelder, Oliver Distler. Arthritis Rheumatol 2015
83
13

The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease.
Anna-Maria Hoffmann-Vold, Yannick Allanore, Elisabeth Bendstrup, Cosimo Bruni, Oliver Distler, Toby M Maher, Marlies Wijsenbeek, Michael Kreuter. Respir Res 2020
10
20

Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
Anna-Maria Hoffmann-Vold, Trond M Aaløkken, May Brit Lund, Torhild Garen, Øyvind Midtvedt, Cathrine Brunborg, Jan Tore Gran, Øyvind Molberg. Arthritis Rheumatol 2015
72
13

Mortality and survival in systemic sclerosis: systematic review and meta-analysis.
Manuel Rubio-Rivas, Cristina Royo, Carmen Pilar Simeón, Xavier Corbella, Vicent Fonollosa. Semin Arthritis Rheum 2014
131
13

High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.
David Launay, Martine Remy-Jardin, Ulrique Michon-Pasturel, Ioana Mastora, Eric Hachulla, Marc Lambert, Valerie Delannoy, Viviane Queyrel, Alain Duhamel, Regis Matran,[...]. J Rheumatol 2006
116
13

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.
Tatiana Barskova, Luna Gargani, Serena Guiducci, Silvia Bellando Randone, Cosimo Bruni, Giulia Carnesecchi, Maria Letizia Conforti, Francesco Porta, Alberto Pignone, Davide Caramella,[...]. Ann Rheum Dis 2013
87
13

Prognostic Value of Lung Ultrasound B-Lines in Systemic Sclerosis.
Luna Gargani, Cosimo Bruni, Chiara Romei, Paolo Frumento, Antonella Moreo, Gergely Agoston, Serena Guiducci, Silvia Bellando-Randone, Gemma Lepri, Laura Belloli,[...]. Chest 2020
13
15

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
Demosthenes Bouros, Athol U Wells, Andrew G Nicholson, Thomas V Colby, Vlasis Polychronopoulos, Panos Pantelidis, Patricia L Haslam, Dimitris A Vassilakis, Carol M Black, Roland M du Bois. Am J Respir Crit Care Med 2002
460
13

Pulmonary function tests.
J Behr, D E Furst. Rheumatology (Oxford) 2008
40
13

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
U A Walker, A Tyndall, L Czirják, C Denton, D Farge-Bancel, O Kowal-Bielecka, U Müller-Ladner, C Bocelli-Tyndall, M Matucci-Cerinic. Ann Rheum Dis 2007
520
13

Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.
Jürgen Behr, Petra Neuser, Antje Prasse, Michael Kreuter, Klaus Rabe, Carmen Schade-Brittinger, Jasmin Wagner, Andreas Günther. BMC Pulm Med 2017
51
13

Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.
Boris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, Shreosi Sanyal, Pierre-Yves Brillet, Michel Brauner, Marianne Kambouchner, Sophie Huynh, Jean Marc Naccache, Raphael Borie,[...]. Eur Respir J 2017
87
13

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
854
13

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.
Kevin R Flaherty, Kevin K Brown, Athol U Wells, Emmanuelle Clerisme-Beaty, Harold R Collard, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Florence Le Maulf, Luca Richeldi,[...]. BMJ Open Respir Res 2017
93
13

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
140
13

Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease.
Anna-Maria Hoffmann-Vold, S Samuel Weigt, Rajan Saggar, Vyacheslav Palchevskiy, Elizabeth R Volkmann, Lloyd L Liang, David Ross, Abbas Ardehali, Joseph P Lynch, John A Belperio. EBioMedicine 2019
15
13

Ultrasound in the Assessment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Literature Review by the OMERACT Ultrasound Group.
Marwin Gutierrez, Carina Soto-Fajardo, Carlos Pineda, Alfonso Alfaro-Rodriguez, Lene Terslev, George Bruyn, Annamaria Iagnocco, Chiara Bertolazzi, Maria Antonietta D'Agostino, Andrea Delle Sedie. J Rheumatol 2020
11
18

Lung Ultrasound as a Screening Method for Interstitial Lung Disease in Patients With Systemic Sclerosis.
Romina Isabel Hassan, Lucia I Lubertino, Maria Angeles Barth, Maria Fernanda Quaglia, Sandra Fabiana Montoya, Eduardo Kerzberg, Maria Del Carmen Binda. J Clin Rheumatol 2019
10
20

Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality.
Karina Raimundo, Joshua J Solomon, Amy L Olson, Amanda M Kong, Ashley L Cole, Aryeh Fischer, Jeffrey J Swigris. J Rheumatol 2019
58
13

Ultrasound screening for interstitial lung disease in rheumatoid arthritis.
F C Moazedi-Fuerst, S M Kielhauser, S Scheidl, N J Tripolt, A Lutfi, B Yazdani-Biuki, C Dejaco, W B Graninger. Clin Exp Rheumatol 2014
25
13


Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial.
Kristin B Highland, Oliver Distler, Masataka Kuwana, Yannick Allanore, Shervin Assassi, Arata Azuma, Arnaud Bourdin, Christopher P Denton, Jörg H W Distler, Anna Maria Hoffmann-Vold,[...]. Lancet Respir Med 2021
19
13

Development and Assessment of Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Systemic Sclerosis.
Robert Fairchild, Melody Chung, Diana Yang, Laurel Sharpless, Shufeng Li, Lorinda Chung. Arthritis Care Res (Hoboken) 2021
4
50

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Jeong Seok Lee, Eun Young Lee, You-Jung Ha, Eun Ha Kang, Yun Jong Lee, Yeong Wook Song. Arthritis Res Ther 2019
40
13

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
Tracy J Doyle, Avignat S Patel, Hiroto Hatabu, Mizuki Nishino, Guodong Wu, Juan C Osorio, Maria F Golzarri, Andres Traslosheros, Sarah G Chu, Michelle L Frits,[...]. Am J Respir Crit Care Med 2015
75
13

Tumour markers in rheumatoid arthritis-associated interstitial lung disease.
Ting Wang, Xing-Ju Zheng, Yu-Lin Ji, Zong-An Liang, Bin-Miao Liang. Clin Exp Rheumatol 2016
17
13

Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
Tim Bongartz, Carlotta Nannini, Yimy F Medina-Velasquez, Sara J Achenbach, Cynthia S Crowson, Jay H Ryu, Robert Vassallo, Sherine E Gabriel, Eric L Matteson. Arthritis Rheum 2010
331
13

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Hiroshi Ohnishi, Akihito Yokoyama, Keiichi Kondo, Hironobu Hamada, Masahiro Abe, Kazutaka Nishimura, Kunio Hiwada, Nobuoki Kohno. Am J Respir Crit Care Med 2002
265
13


18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study.
Emmanuel Ledoult, Maxime Morelle, Michael Soussan, Arsène Mékinian, Hélène Béhal, Vincent Sobanski, Eric Hachulla, Damien Huglo, Noémie Le Gouellec, Martine Remy-Jardin,[...]. Arthritis Res Ther 2021
3
66


Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease.
Renea Jablonski, Sangeeta Bhorade, Mary E Strek, Jane Dematte. Chest 2020
13
15

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai, Victoria P Werth, Clarissa Pilkington, Marianne de Visser, Lars Alfredsson, Anthony A Amato, Richard J Barohn, Matthew H Liang,[...]. Ann Rheum Dis 2017
268
13

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
416
13


Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
361
13

Role of a Regional Multidisciplinary Conference in the Diagnosis of Interstitial Lung Disease.
Japnam S Grewal, Julie Morisset, Jolene H Fisher, Andrew M Churg, Ana-Maria Bilawich, Jennifer Ellis, John C English, Cameron J Hague, Nasreen Khalil, Jonathon Leipsic,[...]. Ann Am Thorac Soc 2019
21
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.